The slip
PARKINSON RECEIPTno. 10443
26 Oct 2026, 03:34 UTColigodendrocytes, braak
predictionSORCS3 in oligodendrocytes tracks Braak Lewy-body stage
registeredb1054e81a889270d
discovery+0.82 p=0.0064 n=9
replication-0.54 p=0.130 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery +0.82 p 0.0064; held-out -0.54 p 0.130)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE080d5a8651296372fa93d014…
follows c44c58785d2c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 10443: SORCS3 in oligodendrocytes, braak
- power
- full sample -0.06 (p 0.807, n 18), 95% CI -0.51 to +0.42. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.10 (p 0.702, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.05 (p 0.834, n 18). could be the mix.
- skeptic
- leave-one-out range -0.16 to +0.07, sign flips 4; without severely affected donors -0.06 (p 0.807, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SORCS3 in oligodendrocytes.
case closed: nothing better to follow up.